Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Cash from Financing Activities of -$864000.0 for Q1 2026, down 325.62% year-over-year from $382952.0 in Q1 2025, and down 114.27% quarter-over-quarter from $6.1 million in Q4 2025.
Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$864000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 325.62% year-over-year to -$864000.0; the TTM figure through Mar 2026 stood at $39.8 million (down 46.72% YoY), while the FY2025 annual figure was $40.4 million, down 67.88% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$864000.0, down from $6.1 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $84.5 million in Q2 2023, with the low at -$864000.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $1.7 million (2022), against an average of $20.7 million.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities surged 114501.54% in 2024, then plunged 325.62% in 2026.
- Establishment Labs Holdings' Cash from Financing Activities stood at $25.0 million in 2022, then sank by 99.74% to $65000.0 in 2023, then soared by 114501.54% to $74.5 million in 2024, then sank by 91.87% to $6.1 million in 2025, then tumbled by 114.27% to -$864000.0 in 2026.
- Business Quant data shows ESTA's Cash from Financing Activities at -$864000.0 in Q1 2026, $6.1 million in Q4 2025, and $29.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 23.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.46 Mn |
| Jun 30, 2026 | 23.46 Mn |
| Mar 31, 2026 | -864,000.00 |
| Mar 31, 2026 | -864,000.00 |
| Dec 31, 2025 | 6.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 29.45 Mn |
| Sep 30, 2025 | 29.45 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.13 Mn |
| Mar 31, 2025 | -203,000.00 |
| Mar 31, 2025 | -203,000.00 |
| Dec 31, 2024 | 74.49 Mn |
| Dec 31, 2024 | 74.49 Mn |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Jun 30, 2024 | 389,000.00 |
| Jun 30, 2024 | 389,000.00 |
| Mar 31, 2024 | 51.04 Mn |
| Mar 31, 2024 | 51.04 Mn |